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Fetal tissues, including the placenta, have been shown to contain sig-
nificant amounts of prostaglandins (PG) and also to have the capacity to
synthesize PG. Furthermore, PGE2 and F2 have been demonstrated in fetal
blood, but circulating levels drop rapidly after birth. PGEi infusion
into fetal lambs produced a marked increase in blood flow to the lungs,
myocardium, adrenal gland, and musculo-skeletal System. However, the
studies do not indicate the role of PCs in normal regulation of circu-
latory function in the fetal lamb in utero. Administration of drugs
that inhibit synthesis of PCs provides the opportunity to assess their
role.
Inhibition of PG synthesis in fetal lambs in utero produced a small
increase in conibined ventricular Output ,and in umbilical-placental blood
flow, a marked increase in myocardial and adrenal flows, and a small rise
in pulmonary flow. Blood flow to the peripheral and gastrointestinal
circulations were reduced. PCs thus do not have a significant role in
regulating blood flow to the placenta or the lungs in the normal fetus
but may exert a mild peripheral vasodilator effect.
Evidence is increasing that PCs have an important role in maintaining
dilatation of the ductus arteriosus during fetal life. PGEi and PGE2
produced striking relaxation of isolated Strips of ductus arteriosus
obtained from fetal lambs. We found that acetylsalicylic acid, indo-
methacin, or naproxen resulted in constriction of the ductus, with a rise
in pulmonary arterial pressure in fetal lambs in utero (2) . It is not
known whether the ductus is influenced by locally-produced PCs alone or
also by circulating PCs. The ductus arteriosus produces PGE2 and PGF2a
in small amounts, but the main PG found was 6-keto-PGFia, a metabolic
product of the more active precursor, prostacyclin or PGI2. However,
PGE2 has a much greater dilator action on the lamb ductus arteriosus
than does PGI2, on a molar concentration basis (1). The relative roles
of oxygen and of removal of the PG relaxation effect, in constriction of
the ductus arteriosus after birth, have not been resolved. Since
circulating PG levels fall rapidly after birth, removal of their effect
on the ductus may be important in postnatal ductus closure.
The dilator effect of PGEi and E2 on the ductus arteriosus has been
used to treat infants with congenital heart disease in whom the ductus
is important in maintaining pulmonary or systemic blood flow. In
infants with lesions that obstruct right ventricular out flow, pulmonary
blood flow after birth is dependent on flow from the aorta through the
ductus arteriosus. In infants with pulmonary atresia, while the ductus
is open, pulmonary flow is adequate and there is mild hypoxia. Con-
striction of the ductus decreases pulmonary flow and results in severe
hypoxia. PGEi has been infused at rates of 0.05 - 0.1 micrograms/kg
per minute in these infants with dramatic improvement in P02 (3).
Infants with Interruption of the aortic arch are dependent on the ductus
arteriosus to provide blood flow from the pulmonary artery to the
descending aorta. When the ductus constricts, blood flow and arterial
pressure in the descending aorta decrease. Infusion of PGEi may result
in a marked increase in descending aortic pressure and decrease of the
pressure gradient across the ductus arteriosus in these infants.
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There is a high incidence of persistent patency of the ductus arteriosus in
premature infants, especially those under 1500g in weight. The patent
ductus frequently results in cardiorespiratory failure, which may not
respond to treatment with digitalis and diuretic drugs and many premature
infants have required surgical ligation of the ductus. Since indomethacin
constricted the ductus arteriosus in fetal rodents and lambs, we tested the
Potential of the drug to close the ductus in premature infants with cardio-
respiratory failure unresponsive to digitalis and diuretics (4). Indo-
methacin is given either by orogastric tube, äs a Suspension, or, if avail-
able, intravenously äs the lyophilized preparation in a dose of 0.2 mg/kg
body weight. If there is an excellent response, no further therapy is
indicated. If there is no response or only a partial response, a second
and, if necessary, a third dose is given after 8-12 hours intervals. If no
response occurs, no further indomethacin therapy is advised, in view of the
risk of complications. The most ijnportant cömplication is oliguria, which
may progress to anuria. In our experience with the first 100 infants, 70
showed good clinical response and did not require further therapy; 10
showed good initial response but Symptoms returned within a week and they
required a second course of therapy with good mäintained improvement; 5
infants responded partially and still needed digitalis and diuretic therapy;
15 babies showed inadequate or no response and required surgical ligation.
In view of the effectiveness of indomethacin, we no longer use digitalis
drugs in initial treatment of cardiorespiratory failure in premature infants
with patent ductus arteriosus, but administer indomethacin. Current cqntra-
indications to its use include necrotizing enterocolitis, bleeding tenden-
cies, and serum creatinine level above 1.6 mg/dl.
Since PG synthesis inhibitors readily cross the placenta, they have the
capability of constricting the ductus arteriosus in the fetus when adminis-
tered to the mother; constriction of the ductus results in an increase in
pulmonary arterial pressure. In studies in fetal lambs we demonstrated that
a prolonged rise in pulmonary arterial pressure stimulates the growth of the
smooth muscle in the precapillary arterioles of the lung (5). The possibil-
ity that this increased pulmonary vascular medial muscle development may be
responsible for the clinical syndrome of persistent pulmonary hypertension,
or persistent fetal circulation in the newborn infant, has been considered.
There is already evidence to indicate that persistent pulmonary hyper-
tension occurs in human infants when mothers have ingested aspirin or indo-
methacin. The condition results from an inability for. the pulmonary circu-
lation to undergo the usual dilatation after birth, so that pulmonary vas-
cular resistance remains high and there is thus an inadequate pulmonary
blood flow with right-to-left shunting through the foramen ovale with
marked cyanosis.
We are not sure how frequently prostaglandin synthesis inhibitors results
in this syndrome in human infants. Factors that may influence the effects on
the pulmonary circulation are the duration of therapy, dose administered,
and period of gestation when ingested. However, until these factors are
determined, caution should be exercised in administering drugs which inhibit
prostaglandin synthesis to pregnant women.
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